Our results indicated that expression levels of PD-1 on CD4+ and CD8+ T lymphocytes were significantly increased in newly diagnosed and non-remission patients compared to healthy controls both in AML and ALL patients. This evidence concerns the gene CD4 and acute myeloid leukemia.